314 related articles for article (PubMed ID: 22737441)
1. Genetic and epigenetic changes in human prostate cancer.
Koochekpour S
Iran Red Crescent Med J; 2011 Feb; 13(2):80-98. PubMed ID: 22737441
[TBL] [Abstract][Full Text] [Related]
2. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.
Xavier MJ; Roman SD; Aitken RJ; Nixon B
Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565
[TBL] [Abstract][Full Text] [Related]
3. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
4. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
5. The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates.
Ather MH; Siddiqui T
Appl Clin Genet; 2012; 5():105-10. PubMed ID: 23776386
[TBL] [Abstract][Full Text] [Related]
6. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications in prostate cancer.
Sugiura M; Sato H; Kanesaka M; Imamura Y; Sakamoto S; Ichikawa T; Kaneda A
Int J Urol; 2021 Feb; 28(2):140-149. PubMed ID: 33111429
[TBL] [Abstract][Full Text] [Related]
8. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modifications and Therapy in Multiple Sclerosis.
Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
[TBL] [Abstract][Full Text] [Related]
10. The promise and failures of epigenetic therapies for cancer treatment.
Bojang P; Ramos KS
Cancer Treat Rev; 2014 Feb; 40(1):153-69. PubMed ID: 23831234
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer.
Kumaraswamy A; Welker Leng KR; Westbrook TC; Yates JA; Zhao SG; Evans CP; Feng FY; Morgan TM; Alumkal JJ
Eur Urol; 2021 Jul; 80(1):71-81. PubMed ID: 33785255
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.
Madkour MM; Ramadan WS; Saleh E; El-Awady R
Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of prostate cancer: beyond DNA methylation.
Schulz WA; Hatina J
J Cell Mol Med; 2006; 10(1):100-25. PubMed ID: 16563224
[TBL] [Abstract][Full Text] [Related]
14. Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians.
Merseburger AS; Waldron N; Ribal MJ; Heidenreich A; Perner S; Fizazi K; Sternberg CN; Mateo J; Wirth MP; Castro E; Olmos D; Petrylak DP; Chowdhury S
Eur Urol; 2021 Apr; 79(4):519-529. PubMed ID: 33494937
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
17. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation and prostate cancer.
Majumdar S; Buckles E; Estrada J; Koochekpour S
Curr Genomics; 2011 Nov; 12(7):486-505. PubMed ID: 22547956
[TBL] [Abstract][Full Text] [Related]
20. Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation.
Pandareesh MD; Kameshwar VH; Byrappa K
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):253-267. PubMed ID: 32682386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]